10.1016/j.addr.2021.04.003 146 SandsE.KivitzA.DehaanW.LeungS
Statements Author contributions YW: Investigation, Writing original draft
Likelihood of Accepting Treatment of GLP-1 vs Existing MOUD Options Does offering semaglutide or tirzepatide as one of the options for AUD or OUD treatment increase the likelihood of patients accepting treatment vs only offering existing therapies like naltrexone, buprenorphine, or methadone
Nr du vurderer en udbyder, br du se p, hvordan brugerrejsen fles fra frste klik til udbetaling, hvilke spil der er tilgngelige, og hvordan udvalget passer til dine prferencer, hvad enten du foretrkker klassiske bordspil eller moderne videoautomater med temaer, jackpots og interaktive bonusrunder
GLP-1 RA and atrial fibrillation in the cardiovascular outcome trials
Metabolic symptoms include unexplained heat intolerance, excessive sweating, or feeling warm when others are comfortable